You Searched For "Favipiravir tablets" and got 20 results
Sort By:
Brinton Pharma, which recently got DCGI approval to launch COVID-19 drug Favipiravir in India, gets ₹10 crore in debt funding
Pune-based Brinton Pharmaceuticals has raised ₹10 crore in debt funding from BlackSoil Capital, a n…
Indoco Remedies launches 400mg tablets of Favipiravir in India
Indoco Remedies, on September 26, launched its own version of generic Favipiravir under the brand n…
FDC launches two variants of COVID-19 drug Favipiravir in India at ₹55 per tablet
FDC has launched two variants of Favipiravir in India at ₹55 per tablet under the brand names PiFLU…
Glenmark Pharma gets DCGI nod for clinical trials of Favipiravir tablets on COVID-19 patients
Having internally developed the active pharmaceutical ingredients (API) and the formulations for t…
PTI
Strides develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatment
The product is currently being exported to Gulf Cooperation Council (GCC) countries to treat patie…
PTI
Glenmark shares hit upper circuit twice as its COVID-19 drug enters phase-3 clinical trial
The shares of Glenmark Pharmaceuticals climbed over 32% hitting the upper circuit set by the stock …
There are five companies making Favipiravir now — and it is good for supply and prices
After Glenmark and Cipla, two more Indian pharma companies — Sun Pharmaceuticals and Zendara Pharma…
Glenmark announces 400 mg 'FabiFlu' for Covid-19 treatment
Glenmark Pharmaceuticals, a research-led global pharmaceutical company, on Thursday announced that …
COVID-19 treatment: Dr Reddy's partners with Fujifilm, GRA for favipiravir
Fujifilm will provide Dr Reddy's and GRA an array of data on Avigan's preclinical and clinical stud…
PTI
Remdesivir, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts
Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…
PTI
Remdesiver, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts
Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…
PTI
Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients
"Several health and medical experts, both in and outside of Glenmark are eager to see the effect t…
PTI
Glenmark launches Favipiravir:Medics say 'no magic bullet' for COVID but will help amid rising cases
"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patie…
PTI
Anti-viral drug favipiravir gets nod for restricted emergency use in mild to moderate COVID-19 cases
"This emergency use authorisation has been granted with certain conditions which include taking wri…
PTI
Glenmark launches COVID-19 drug at Rs 103 per tablet
When asked if the company is looking for tie-ups with hospitals for supply of the drug, it said: "O…
PTI
Glenmark cuts price of COVID-19 drug by 27 pc to Rs 75 per tablet
When asked about the company's manufacturing capacity of the drug, Glenmark had earlier said: "Cons…
PTI
Glenmark Pharma cuts price of COVID-19 drug by 27 pc to Rs 75/tablet
"Our internal research shows us that we launched FabiFlu in India at the lowest market cost as com…
PTI
Glenmark Pharma shares jump nearly 9 pc on DCGI nod for clinical trials of COVID-19 tablets
Having internally developed the active pharmaceutical ingredients (API) and the formulations for th…
PTI
Glenmark Pharmaceuticals shares soar 20 pc after COVID-19 drug launch
The drug firm on Saturday said it has launched antiviral drug FabiFlu for the treatment of patient…
PTI
Glenmark Pharma shares soar 27 pc after COVID-19 drug launch
The drug firm on Saturday said it has launched antiviral drug FabiFlu for the treatment of patients…